Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 -0.00124999999999997
Stock impact report

RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit [Yahoo! Finance Canada]

ACCESS Newswire Inc. (ACCS) 
LAS VEGAS, NEVADA / ACCESS Newswire / November 18, 2025 / Regenerative Medical Technologies Group, Inc. (OTC:RMTG), a global leader in regenerative medicine solutions, today announced the successful introduction of its CELLGENIC Peptide Pen product line, officially presented during the ISSCA Global Summit held in Cancún. The new line represents an important step toward simplifying and modernizing peptide therapy within the field of regenerative and longevity medicine, while creating additional revenue opportunities through RMTG's established physician network. Product Innovation and Revenue Potential: The CELLGENIC Peptide Pen series was designed to offer physicians a more practical approach to peptide therapy. Each pre-loaded device contains synergistic peptide formulations that support various clinical goals such as recovery, immune balance, metabolic optimization, and overall wellness. By integrating multiple compounds into a single, ready-to-use pen, the product streamlines p Show less Read more
Impact Snapshot
Event Time:
ACCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ACCS alerts

from News Quantified
Opt-in for
ACCS alerts

from News Quantified